HCW Biologics Stock Forward View - Accumulation Distribution
| HCWB Stock | USD 0.38 0.01 2.46% |
This page provides Accumulation Distribution reference data for HCW Biologics, calculated from historical daily prices. The model output shown here is derived from HCW Biologics's historical price series and is provided for informational purposes. Projected values and accuracy measures are included for reference.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The Accumulation Distribution reference information for HCW Biologics is based on available price data and is intended for informational purposes. Accumulation Distribution Analysis Today
HCW Biologics has current Accumulation Distribution of 0.0263. The accumulation distribution (A/D) indicator shows the degree to which HCW Biologics is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of HCW Biologics to determine if accumulation or reduction is taking place in the market. This value is adjusted by HCW Biologics trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 94812.0 | 0.0263 |
| Volatility | Backtest | Information Ratio |
HCW Biologics Trading Date Momentum
| On March 27 2026 HCW Biologics was traded for 0.38 at the closing time. The top price for the day was 0.38 and the lowest listed price was 0.37 . There was no trading activity during the period. Lack of trading volume on March 27, 2026 did not cause price change. The trading delta at closing time against the current closing price is -2.40% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare HCW Biologics to competition |
Other Forecasting Options for HCW Biologics
The autocorrelation structure of HCW Biologics' daily returns reveals whether HCW exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements helps distinguish persistent directional moves from temporary noise in HCW Stock price data. Stochastic oscillator analysis compares HCW Biologics' closing price to its range over a given period.HCW Biologics Related Equities
These related stocks within the Health Care space give benchmarks for judging HCW Biologics' results, margins, and growth trend. Profit comparisons show whether HCW Biologics earns above or below average returns next to its peers. Identifying peers that steadily beat or lag HCW Biologics across many periods highlights durable competitive gaps. The peer review below gives a clear framework for judging HCW Biologics' standing among rivals.
| Risk & Return | Correlation |
HCW Biologics Market Strength Events
Market strength indicators applied to HCW Biologics stock help assess momentum and resilience across environments. These indicators support informed market timing decisions when analyzing HCW Biologics. For HCW Biologics, market strength indicators complement fundamental analysis with timing context.
HCW Biologics Risk Indicators
Risk indicator analysis for HCW Biologics is essential for accurately projecting its future price trajectory. The process involves identifying the amount of risk involved in HCW Biologics' investment and either accepting or mitigating it. Understanding the risk profile of HCW Biologics' allows investors to make more informed decisions about position sizing.
| Mean Deviation | 6.69 | |||
| Standard Deviation | 13.1 | |||
| Variance | 171.5 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for HCW Biologics
A coverage review of HCW Biologics shows when the security is attracting above-average attention from contributors and market observers. The practical risk is that faster visibility can increase both interest and skepticism at the same time.
Contributor Headline
Latest Perspective From Macroaxis
HCW Biologics Short Properties
Short-interest signals around HCW Biologics can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 38.8 M | |
| Cash And Short Term Investments | 4.7 M |